Oncology Clinical Trials in Fargo, ND
As of September 2026, 54 paid clinical trials are recruiting for Oncology in Fargo, North Dakota. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
54 clinical trials for Oncology
·Clear filters·A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)
A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
E-Mindfulness Approaches for Living After Breast Cancer
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Project: Every Child for Younger Patients With Cancer
Top Research Study Locations in Fargo
Researchers run research studies in Fargo, ND at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Sanford Broadway Medical Center | Malignant Solid Neoplasm, Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8 | 76 |
| Sanford Roger Maris Cancer Center | Malignant Solid Neoplasm, Stage IV Lung Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 59 |
| Essentia Health Cancer Center-South University Clinic | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Advanced Esophageal Adenocarcinoma | 43 |
| Sanford Medical Center Fargo | Malignant Solid Neoplasm, Hematopoietic and Lymphoid Cell Neoplasm, Acute Lymphoblastic Leukemia | 14 |
| Sanford South University Medical Center | Malignant Solid Neoplasm, Hematopoietic and Lymphoid Cell Neoplasm, Acute Lymphoblastic Leukemia | 14 |
| Southpointe-Sanford Medical Center Fargo | Malignant Solid Neoplasm, Hematopoietic and Lymphoid Cell Neoplasm, Acute Lymphoblastic Leukemia | 13 |
| Sanford Health | Pregnancy, ACL Injury, Advanced Cancer | 9 |
| Lillestol Research | Chronic Pain, Osteoarthritis, Knee, Overweight | 8 |
| Sanford Fargo Medical Center | Breast Neoplasms, Extensive-Stage Small Cell Lung Cancer, Multiple Myeloma | 8 |
| Sanford Fargo Medical Center-Roger Maris Cancer Center | Triple-Negative Breast Cancer, Non Small Cell Lung Cancer, B-cell Acute Lymphoblastic Leukemia | 5 |
| Lillestol Research LLC | Obesity, Overweight, Cardiovascular Disease | 4 |
| Red River Research Partners | Atopic Dermatitis (AD), Hidradenitis Suppurativa, NonSegmental Vitiligo | 3 |
| Red River Research Partners, LLC | Atopic, Atopic Dermatitis, Dermatitis | 3 |
| Inmagene | Atopic Dermatitis, Atopic Dermatitis Eczema, Eczema | 2 |
| Lillestol Research, LLC | Cardiovascular Diseases, Chronic Idiopathic Constipation (CIC), Diabetes Mellitus, Type 2 | 2 |
| Sanford Fargo | Head and Neck Squamous Cell Carcinoma, Moderate Aortic Valve Stenosis | 2 |
| Sanford Medical Center | Lumbar Spinal Stenosis, Open tíbia Fracture | 2 |
| Vance Thompson Vision | Astigmatism, Myopia, Pseudoexfoliation Glaucoma | 2 |
| AXIS Clinicals - Fargo | Prurigo Nodularis, Pruritus | 2 |
| Plains Clinical Research Center | Chronic Obstructive Pulmonary Disease, Crohn's Disease | 2 |
| Sanford Health Roger Maris Cancer Center | Malignant Neoplasm, Diffuse Large B-Cell Lymphoma | 2 |
| Axis Clincals USA/ Red River Research Patners. LLC | Psoriasis | 1 |
| Bergstrom Eye Research LLC | Age-Related Macular Degeneration | 1 |
| CBCC Global Research Site:003 | Age-related Wet Macular Degeneration | 1 |
| Call for Information | Classical Hodgkin Lymphoma, Lymphoma, Melanoma | 1 |
Active & Upcoming Studies in Fargo (2026)
Recruiting trials in Fargo grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (105 active studies)
- A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment · Phase 2 · Alliance for Clinical Trials in Oncology
- Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia · Phase 3 · Children's Oncology Group
Diabetes & metabolic (15 active studies)
- A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide · Phase 3 · Novo Nordisk A/S
- A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity · Phase 3 · Eli Lilly and Company
Neurology & pain (8 active studies)
- A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain · Phase 2 · Eli Lilly and Company
Eye & vision (5 active studies)
- A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated · Phase 1, Phase 2 · Boehringer Ingelheim
- A Multicenter, Open-Label Study to Evaluate Perioperative Treatment of Dry Eye With Miebo® in Subjects Undergoing LASIK · Phase 4 · Vance Thompson Vision
Cardiovascular (4 active studies)
- A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF · Phase 3 · AstraZeneca
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
Mental health & behavior (2 active studies)
- E-Mindfulness Approaches for Living After Breast Cancer · Phase 3 · NRG Oncology
- Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program · Phase 3 · Alliance for Clinical Trials in Oncology
Vaccines (1 active study)
Common conditions studied in Fargo
- Malignant Solid Neoplasm (6 active studies)
- Obesity (6 active studies)
- Overweight (6 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (5 active studies)
- Melanoma (5 active studies)
- Acute Myeloid Leukemia (4 active studies)
Leading research sponsors in Fargo
- National Cancer Institute (NCI)
- Alliance for Clinical Trials in Oncology
- Children's Oncology Group
- SWOG Cancer Research Network
- Merck Sharp & Dohme LLC
Frequently asked questions
How many paid clinical trials are currently recruiting in Fargo?
There are approximately 189 recruiting clinical trials in Fargo, North Dakota listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Fargo pay participants?
Most recruiting trials in Fargo compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Fargo?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Fargo?
The most common conditions under active study in Fargo include Malignant Solid Neoplasm (6), Obesity (6), Overweight (6), Anatomic Stage II Breast Cancer AJCC v8 (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Fargo?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Fargo on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Fargo?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Fargo?
Recruiting research sites in Fargo include Sanford Broadway Medical Center, Sanford Roger Maris Cancer Center, Essentia Health Cancer Center-South University Clinic, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Fargo right now?
The largest active categories in Fargo are Cancer & tumors (105), Diabetes & metabolic (15), Neurology & pain (8). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.